Home > Insider Trading > Filing (0000313143-13-000073)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
313143	Haemonetics Corp	HAE	Surgical & Medical Instruments & Apparatus (3841)	042882273

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1266051	J Christopher Lindop	400 Wood Road Braintree MA 02184	Cfo & Evp Business Development	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-04-30	412	$32.73	31,522	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Non-Qualified Stock Option (right to buy)	$26.32	2009-10-23	2015-10-23	98,040	98,040	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$26.47	2010-10-27	2016-10-27	44,072	44,072	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$27.28	2009-10-22	2015-10-22	42,882	42,882	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$27.50	2011-10-27	2017-10-27	50,190	50,190	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$30.67	2012-10-25	2018-10-25	48,306	48,306	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$39.06	2013-10-24	2019-10-24	46,498	46,498	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2015-10-23	98,040	98,040	Direct
2016-10-27	44,072	44,072	Direct
2015-10-22	42,882	42,882	Direct
2017-10-27	50,190	50,190	Direct
2018-10-25	48,306	48,306	Direct
2019-10-24	46,498	46,498	Direct

Footnotes

Acquisition of shares of Common Stock pursuant to the Employee Stock Purchase Plan. Participant elected to purchase shares at least six months in advance of the effective date of the transaction.
Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
Grant to reporting person of right to buy shares of common stock vesting in annual increments over a 5 year period beginning on the first anniversary of the date of grant.
Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.